Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-230.12	-180.06	-54.54
Graham Fair Price	-56.69	27243.42	62897.22
PEG	1284.73	0.47	-0.03
Price/Book	29.19	2.77	2.14
Price/Cash Flow	-38.58	-12.24	-8.83
Prices/Earnings	-627.31	-38.10	-5.24
Price/Sales	-16.91	9.66	11.62
Price/FCF	-38.58	-12.24	-8.83
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-96.35	-0.06	1.59
Operating Margin	43.96	-0.18	-0.33
ROA	81.99	< 0.005	-0.02
ROE	-0.10	-0.02	82.24
ROIC	-0.02	-0.01	18.07
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	0.04	0.05	-26.13
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	-0.91	0.10	-88.46
EPS QOQ	-1.56	0.82	-47.48
FCF QOQ	-0.38	0.04	-88.94
Revenue QOQ	-0.53	0.60	13.25
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	-196.09	56.45	-71.21
Days Sales Outstanding (DSO)	403.39	69.11	-82.87
Inventory Turnover	-0.46	1.59	247.37
Debt/Capitalization	0.71	0.71	0.12
Quick Ratio	0.95	0.73	-22.81
Naive Interpretation	member

04 - Leverage & Liquidity · Bad

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	41487.71	42638.43	2.77
Cash	17156.22	31487.75	83.54
Capex	-10345.44	-8361.38	19.18
Free Cash Flow	-10051.42	-9629.88	4.19
Revenue	7640.75	12209.59	59.80
Naive Interpretation	member

05 - Per Share Metrics · Best

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	1.13	0.98	-12.66
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-26.77	-71.87	-168.43
Naive Interpretation	Member

06 - Financial Health · Bad

Rating